PARTNER NEWS:Thu, May 2, 8:42 AM, Zacks
Reasons to Retain Quest Diagnostics (DGX) Stock for Now
Investors are optimistic about Quest Diagnostics (DGX) on strong legacy business growth.
Thu, May 2, 7:02 AM, Zacks
Quest Diagnostics (DGX) Inks Deal to Acquire PathAI Diagnostics
Quest Diagnostics (DGX) latest transaction combines its oncology expertise and scale with PathAI's AI and digital pathology innovations.